JAMA 329(2):157168 Khan M et al (2020) COVID-19: a global challenge with old history, epidemiology and progress so far
: -10 : 2019 -10 : 2019 L-
If you are losing weight on Ozempic, Wegovy, Mounjaro, or Zepbound and tolerating it well, the injection you are already using is very likely producing more weight loss than orforglipron would
GLP-1 medication changes may support long-term weight management Patients who switch obesity drugs after less than a year stay better engaged with their treatment, UTSW researchers find Patients without diabetes who switched GLP-1 receptor agonist (GLP-1RA) drugs for overweight or obesity were more likely to stick with their treatment longer than those who didnt switch, according to a new study by UT Southwestern Medical Center researchers
We matched the comparison groups using a multivariable logistic regression to estimate the propensity score and performed nearest number matching with a caliper of 0.01 with no replacement, using same technique as our primary analysis
Remission of type 2 diabetes with very low-calorie dietsA
